Targeting Trop-2 as a Cancer Driver

医学 引用 癌症 图书馆学 肿瘤科 内科学 计算机科学
作者
Emanuela Guerra,Marco Trerotola,Saverio Alberti
出处
期刊:Journal of Clinical Oncology [American Society of Clinical Oncology]
卷期号:41 (29): 4688-4692 被引量:6
标识
DOI:10.1200/jco.23.01207
摘要

Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01. June 16, 2023 ARTICLE CITATION DOI: 10.1200/JCO.23.01207 Journal of Clinical Oncology - published online before print August 7, 2023 PMID: 37549340 Targeting Trop-2 as a Cancer Driver Emanuela Guerra , PhD1,2xEmanuela GuerraSearch for articles by this author; Marco Trerotola , PhD1,2xMarco TrerotolaSearch for articles by this author; and Saverio Alberti , MD, PhD3xSaverio AlbertiSearch for articles by this author Show More 1Laboratory of Cancer Pathology, Center for Advanced Studies and Technology (CAST), G. d'Annunzio University of Chieti-Pescara, Chieti, Italy2Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University of Chieti-Pescara, Chieti, Italy3Unit of Medical Genetics, Department of Biomedical Sciences—BIOMORF, University of Messina, Messina, Italy https://doi.org/10.1200/JCO.23.01207 First Page Full Text PDF Figures and Tables © 2023 by American Society of Clinical OncologyAUTHOR CONTRIBUTIONSConception and design: All authorsCollection and assembly of data: All authorsData analysis and interpretation: Emanuela Guerra, Saverio AlbertiManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTTargeting Trop-2 as a Cancer DriverThe following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).Emanuela GuerraStock and Other Ownership Interests: Mediterranea Theranostic SrlResearch Funding: Mediterranea Theranostic SrlPatents, Royalties, Other Intellectual Property: Inventor in patents WO2016087651 and WO2017084763,Saverio AlbertiLeadership: Oncoxx BiotechStock and Other Ownership Interests: Oncoxx BiotechResearch Funding: Oncoxx BiotechPatents, Royalties, Other Intellectual Property: novel anti-cancer drugs and companion diagnosticsTravel, Accommodations, Expenses: Oncoxx BiotechNo other potential conflicts of interest were reported. Companion First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
幸福诗槐完成签到,获得积分20
刚刚
zhangxr发布了新的文献求助10
刚刚
杯子发布了新的文献求助10
1秒前
突突突完成签到,获得积分10
1秒前
ZYC007完成签到,获得积分10
1秒前
2秒前
2秒前
learnerZ_2023完成签到,获得积分10
2秒前
3秒前
橙汁完成签到,获得积分10
3秒前
社恐Forza应助复杂的香菱采纳,获得10
3秒前
lvjia完成签到,获得积分10
4秒前
ljq完成签到 ,获得积分10
4秒前
小白完成签到,获得积分10
5秒前
虚幻的海安完成签到,获得积分10
5秒前
神行太保完成签到,获得积分10
6秒前
科研通AI2S应助lusuoshan采纳,获得10
6秒前
大观天下发布了新的文献求助10
6秒前
苏钰完成签到,获得积分10
7秒前
小刘小刘完成签到 ,获得积分10
7秒前
纪昕完成签到 ,获得积分10
8秒前
8秒前
郭一鸣完成签到,获得积分10
8秒前
qiu发布了新的文献求助10
8秒前
orixero应助sy采纳,获得10
8秒前
如履平川完成签到 ,获得积分10
9秒前
bakasha完成签到,获得积分10
9秒前
10秒前
10秒前
安之完成签到,获得积分10
10秒前
裴南苇完成签到 ,获得积分10
11秒前
以恒之心发布了新的文献求助10
11秒前
陆陆完成签到,获得积分10
12秒前
koala完成签到,获得积分10
13秒前
yuxin发布了新的文献求助10
13秒前
happy2016完成签到 ,获得积分10
13秒前
actor2006完成签到,获得积分10
13秒前
小彭友完成签到 ,获得积分10
13秒前
香蕉觅云应助zhangxr采纳,获得10
14秒前
14秒前
高分求助中
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
宽禁带半导体紫外光电探测器 388
Case Research: The Case Writing Process 300
Global Geological Record of Lake Basins 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3142849
求助须知:如何正确求助?哪些是违规求助? 2793801
关于积分的说明 7807889
捐赠科研通 2450113
什么是DOI,文献DOI怎么找? 1303653
科研通“疑难数据库(出版商)”最低求助积分说明 627017
版权声明 601350